Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

Additional Metadata
Keywords	Bile acid therapy, Cholestatic liver disease, Dose regimen, Histology, Survival
Persistent URL	doi.org/10.1016/S0168-8278(98)80059-7, hdl.handle.net/1765/68742
Journal	Journal of Hepatology
Organisation	Department of Pathology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van Hoogstraten, H., Wolfhagen, F., van de Meeberg, P., Kuiper, H., Nix, G., Becx, M., Hoek, A., van Houte, D. P. F., Rijk, M. C. M., Salemans, J., Scherpenisse, J., Schrijver, M., Smit, A., Spoelstra, P., Stadhouders, R., Tan Gie, T., Hop, W., ten Kate, F., VanBerge-Henegouwen, G., … van Buuren, H. (1998). Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses. Journal of Hepatology, 29(3), 417–423.https://doi.org/10.1016/S0168-8278(98)80059-7

Publication